Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PMVP

PMV Pharmaceuticals Inc

May 06 • 04:00PM ET

1.45

+0.08 5.84 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: AMGN GILD MRNA BIIB INCY VRTX REGN NBIX ALNY BLUE

| Held by: VTI VXF IWC BTEC AVTM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.48	Insider Own	8.34%	Shs Outstand	53.33M	Perf Week	4.32%
Market Cap	77.33M	Forward P/E	-	EPS next Y	-1.16	Insider Trans	0.00%	Shs Float	48.88M	Perf Month	12.40%
Enterprise Value	-34.77M	PEG	-	EPS next Q	-0.41	Inst Own	57.27%	Short Float	4.74%	Perf Quarter	40.78%
Income	-77.74M	P/S	-	EPS this Y	-6.08%	Inst Trans	-7.20%	Short Ratio	3.60	Perf Half Y	3.57%
Sales	0.00M	P/B	0.74	EPS next Y	26.11%	ROA	-50.51%	Short Interest	2.31M	Perf YTD	16.00%
Book/sh	1.96	P/C	0.68	EPS next 5Y	17.70%	ROE	-55.37%	52W High	1.88 -22.87%	Perf Year	66.67%
Cash/sh	2.12	P/FCF	-	EPS past 3/5Y	2.74% -13.98%	ROIC	-73.94%	52W Low	0.81 79.01%	Perf 3Y	-70.41%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	3.56% 4.72%	Perf 5Y	-95.87%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-30.22%	Oper. Margin	-	ATR (14)	0.07	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.09	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	56.00	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.09	EPS Q/Q	23.57%	SMA20	3.13%	Beta	1.41	Target Price	4.67
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	0.96%	Rel Volume	0.33	Prev Close	1.37
Employees	54	LT Debt/Eq	0.00	Earnings	Mar 06 BMO	SMA200	7.90%	Avg Volume	643.81K	Price	1.45
IPO	Sep 25, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.46% -	Trades		Volume	211,206	Change	5.84%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)